PANCREATIC STEATOSIS IS A NEW THERAPEUTIC PROBLEM IN GASTROENTEROLOGY (Literature Review)

Main Article Content

Babajanov Abdumurat Sattarovich
Pulatova Sevara Shamsitdinovna

Abstract

Currently, pancreatic steatosis is a common accidental finding during ultrasound examination of the abdominal cavity for other reasons and represents a new problem in gastroenterology and pancreatology. In this review article we have made an attempt to give a general idea of pancreatic steatosis, etiopathogenesis, diagnostic methods, as it is of particular importance due to its close connection with type 2 diabetes mellitus, non-alcoholic fatty liver disease and cardiovascular diseases.

Article Details

How to Cite
Babajanov Abdumurat Sattarovich, & Pulatova Sevara Shamsitdinovna. (2022). PANCREATIC STEATOSIS IS A NEW THERAPEUTIC PROBLEM IN GASTROENTEROLOGY (Literature Review). Galaxy International Interdisciplinary Research Journal, 10(9), 209–218. Retrieved from https://internationaljournals.co.in/index.php/giirj/article/view/2509
Section
Articles

References

Grigorieva I.N., Efimova O.V., Suvorova T.S. nonalcoholic fatty pancreatic disease and metabolic syndrome: an initiating factor or another component? // experimental and practical gastroenterology. - 2015. - No. 5. - p. 86-91. 2. N. B. Gubergrits, so-called Christian, O. A. Bondarenko. non-alcoholic fatty disease of the pancreas. - Donetsk: swan, 2013. - 236 p. 3. Zvenigorodskaya L.A., Onov’s same metabolic syndrome N.G. clinical and diagnostic features of pancreatic steatosis in patients with metabolic syndrome // Bulletin of family medicine. - 2015. - No. 1-2.- p.32-36. 4. Ivashkin V.T., Shifrin O.S., Sokolina I.A. chronic pancreatitis, pancreatic steatosis and steatopancreatitis. - m.: litterra, 2014. - 240 p. 5. Korneeva, o.n., drapkina, o.m. gastroenterological problems of a patient with overweight // Russian medical news. - 2011. - v.xvi, No. 3. - p. 30-36. 6. Pimanov S.I. pancreatic steatosis - a "blank spot" in pancreatology // medical advice. - 2014. - No. 11. - p.22-26. 7. Starodubova A.V., Kosyura S.D., Livantsova E.N., Varaeva Yu.R., Krasilova A.A. Diagnosis of pancreatic steatosis in obese patients. Bulletin of the pancreatic club. - 2019. - No. 4. - p.30-33. 8. Stepanov Yu.M., Zavgorodnya N.Yu., Lukyanenko O. Yu. Steatosis of the subslinging lesion in children. Part 1. Etiology, epidemiology and pathogenesis // gastroenterology. - 2017. - v.51, No. 1. - pp. 46-55. 9. Stepanov Yu.M., Zavgorodnya N.Yu., Luk’yanenko O.Yu. steatosis of the subscapular cavity in children. Part 2. Factors of risk, possibility of diagnostics and lucidity // gastroenterology. - 2017. - VIP.51, No. 2. - p.144-151.

Fadeenko G.D., Prosolenko K.A., Dubrov K.Yu. pancreatic steatosis within the framework of the metabolic syndrome: an equation with many unknowns // bulletin of the club of pancreatologists. - 2010. - No. 1. - p.21-25. 11. alempijevic t., dragasevic s., zec s., popovic d., milosavljevic t. Non-alcoholic fatty pancreas disease // postgrad. Med. J. - 2017. - vol.93, No. 1098. - r.226-230. 12. Anand r, narula mk, chaudhary v, agrawal r. Total pancreatic lipomatosis with malabsorption syndrome // indian j. Endocrinol. Metab. - 2011. - No. 15. - r.51-53. 13. bi y., wang j.-l., li m.-l., zhou j., sun x.-l. The association between pancreas steatosis and metabolic syndrome: a systematic review and meta-analysis // diabetes metab. Res. Rev. - 2019. - 35, No. 5. - r.3142. 14. blaho m., ditě p., kunovský l., martínek a. Fatty pancreas disease: clinical impact // vnitr. Lek. - 2018. - vol.64, No. 10). - r.949-952. 15. Bojkova m., dite p., kunovsky l., blaho met al. The role of metabolic syndrome in induction of chronic pancreatitis after the first attack of acute pancreatitis – multicentric study // digestive diseases. - 2015. - №33. – р.86-90. 16. Bravo a.a., sheth s.g., chopra s. Liver biopsy // n. Engl. J. Med. -2001. - №344. – р.495-500. 17. Carter r., mouralidarane a., soeda j., ray s., pombo j., saraswati r. Et al. Non-alcoholic fatty pancreas disease pathogenesis: a role for developmental programming and altered circadian rhythms // plos one. – 2014. – vol.9, n3. - e89505. 18. Catanzaro r., cuffari b., italia a., marotta f. Exploring the metabolic syndrome: nonalcoholic fatty pancreas disease // world j. Gastroenterol. – 2016. – vol.22, n34. – p.7660-75. 19. Choi c.w., kim g.h., kang d.h. et al. Associated factors for a hyperechogenic pancreas on endoscopic ultrasound // world j. Gastroenterol. – 2010. - vol.16, n34. –p.4329-34. 20. corte c.d., mosca a., majo f. Et al. Nonalcoholic fatty pancreas disease and nonalcoholic fatty liver disease: more than ectopic fat // clin. Endocrinol. (oxf). – 2015. – vol.83, №5. – р.656-62. 21. dite p., blaho m., bojkova m., jabandziev p., kunovsky l. Nonalcoholic fatty pancreas disease: clinical consequences // dig. Dis. – 2020. - vol.38, n2. – p.143-149. 22. Fraulob j.c., ogg-diamantino r., fernandes-santos c., aguila m.b., mandarim-de-lacerda c.a. a mouse model of metabolic syndrome: insulin resistance, fatty liver and non-alcoholic fatty pancreas disease (nafpd) in c57bl/6 mice fed a high fat diet // j. Clin. Biochem. Nutr. – 2010. - vol.46, n3. – p.212-23. 23. Gaborit b., abdesselam i., kober f. Et al. Ectopic fat storage in the pancreas using 1h-mrs: importance of diabetic status and modulation with bariatric surgery-induced weight loss // int. J. Obes. – 2015. - vol.39, n3. – p.480-7. 24. Guglielmi v., sbraccia p. Type 2 diabetes: does pancreatic fat really matter? // diabetes metab. Res. Rev. – 2018. - vol.34, n2. – p.295-5. 25. Hannukainen j.c., borra r., linderborg k. Et al. Liver and pancreatic fat content and metabolism in healthy monozygotic twins with discordant physical activity // j. Hepatol. – 2011. - vol.54, n3. – p.545-52. 26. Heni m., machann j., staiger h. Et al. Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: anuclear magnetic resonance study // diabetes metab. Res. Rev. – 2010. - vol.26, n3. – p.200-5. 27. Hu h.h., kim h.w., nayak k.s., goran m.i. comparison of fat-water mri and single-voxel mrs in the assessment of hepatic and pancreatic fat fractions in humans // obesity. – 2010. - vol.18, n4. – p.841-7. 28. Jeong h.t., lee m.s., kim m.j. quantitative analysis of pancreatic echogenicity on transabdominal sonography: correlations with metabolic syndrome // j. Clin. Ultrasound. – 2015. - vol.43, n2. – p.98-108. 29. Kim s.y., kim h., cho j.y. et al. Quantitative assessment of pancreatic fat by using unenhanced ct: pathologic correlation and clinical implications // radiology. – 2014. - vol.271, n1. – p.104-12. 30. khoury t., mari a., sbeit w. A novel clinical score predicting the presence of fatty pancreas // j. Clin. Med. – 2021. – 10, №24. – р.5843. 31. koç u., taydaş o. Evaluation of pancreatic steatosis prevalence and anthropometric measurements using non-contrast computed tomography // turk j. Gastroenterol. -2020. – vol.31, n9. – p.640-648. 32. Lee j.s., kim s.h., jun d.w. et al. Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome // world j. Gastroenterol. – 2009. - vol. Vol.15, n15. – p.1869-75. 33. Lesmana c.r.a. gani r.a., lesmana l.a. non-alcoholic fatty pancreas disease (nafpd) as risk factor for pancreatic cancer based on endoscopic ultrasound (eus) examination: a single center experience // jgh open. – 2017. - n152. – p.4-7. 34. Lesmana c.r., pakasi l.s., inggriani s., aidawati m.l., lesmana l.a. prevalence of non-alcoholic fatty pancreas disease (nafpd) and its risk factors among adult medical check-up patients in a private hospital: a large cross sectional study // bmc gastroenterol. – 2015. - vol.15, n1. – p.174. 35. Lingvay i., esser v., legendre j.l. et al. Noninvasive quantification of pancreatic fat in humans // j. Clin. Endocrinol. Metab. – 2009. - n94. – p.4070-76. 36. Majumder s., philip n.a., takahashi n., levy m.j., singh v.p., chari s.t. fatty pancreas: should we be concerned? // pancreas. – 2017. - n46. – p.1251-1258. 37. oh h., park h.j., oh j. Et al. Hyperechoic pancreas on ultrasonography: an analysis of its severity and clinical implications // ultrasonography. – 2022. - vol.41, n2. – p.335-343. 38. Ou h.y., wang c.y., yang y.c., chen m.f., chang c.j. the association between nonalcoholic fatty pancreas disease and diabetes // plos one. – 2013. - vol.8, n5. - e62561. 39. Paul j., veettil a., shihaz h. Pancreatic steatosis: a new diagnosis and therapeutic challenge in gastroenterology // arq. Gastroenterol. – 2021. –vol.100, n41. – p.27487. 40. Pezzilli r., calculli l. Pancreatic steatosis: is it related to either obesity or diabetes mellitus? // world j. Diabetes. – 2014. - vol.5, n4. – p.415-9. 41. Pham y.h., bingham b.a., bell c.s. et al. Prevalence of pancreatic steatosis at a pediatric tertiary care center // south med. J. – 2016. - vol.109, 3. – p.196-8. 42. Pinte l., balaban d.v., băicuş c., jinga m. Non-alcoholic fatty pancreas disease-practices for clinicians // rom. J. Intern. Med. – 2019. - vol.57, n3. – p.209-19.

Popescu a., săftoiu a. Can elastography replace fine needle aspiration? // endosc. Ultrasound. – 2014. - vol. Vol.3, n2. – p.109-17. 44. romana b.s., chela h., dailey f.e., nassir f., tahan v. Non-alcoholic fatty pancreas disease (nafpd): a silent spectator or the fifth component of metabolic syndrome? A literature review // endocr. Metab. Immune disord. Drug. Targets. – 2018. – vol.18, №6. – р.547-554. 45. Rossi a.p., fantin f., zamboni g.a. et al. Predictors of ectopic fat accumulation in liver and pancreas in obese men and women // obesity (silver spring). – 2011. - vol.19, n9. – p.1747-54. 46. Rossi a.p., fantin f., zamboni g.a. et al. Effect of moderate weight loss on hepatic, pancreatic and visceral lipids in obese subjects // nutrit. Diabet. – 2012. - n2. – e32. 47. Saisho y. Butler a.e., meier j.j. et al. Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes // clin. Anat. – 2007. - vol.20, n8. – p.933-42. 48. Sbeit w., khoury t. Fatty pancreas represents a risk factor for acute pancreatitis: a pilot study // pancreas. – 2021. - n50. – p.990-993. 49. Sepe p.s., ohri a. Sanaka s. Et al. A prospective evaluation of fatty pancreas by using eus // gastrointest. Endosc. – 2011. - vol.73, n5. – p.987-93. 50. shah n., rocha j.p., bhutiani n., endashaw o. Nonalcoholic fatty pancreas disease // clin. Pract. – 2019. – vol.34, suppl 1. – р.49-56.